viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 4380
tüüp :
Labor
uurimisrühmad :
Autor :
pealkiri :
Posaconazole (Noxafil®) - Summary of Product Characteristics
publikatsioon :
Merck Sharp & Dohme Limited 2019
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Amikacin sulfate
+
Posaconazole
Caspofungin acetate
+
Posaconazole
Ciprofloxacin lactate
+
Posaconazole
Daptomycin
+
Posaconazole
Dobutamine hydrochloride
+
Posaconazole
Famotidine
+
Posaconazole
Filgrastim
+
Posaconazole
Gentamicin sulfate
+
Posaconazole
Hydromorphone hydrochloride
+
Posaconazole
Levofloxacine
+
Posaconazole
Lorazepam
+
Posaconazole
Meropenem
+
Posaconazole
Micafungin
+
Posaconazole
Morphine sulfate
+
Posaconazole
Norepinephrine bitartrate
+
Posaconazole
Posaconazole
1 mg/ml
2-8°C
24
2 mg/ml
2-8°C
24
1 mg/ml
2-8°C
24
2 mg/ml
2-8°C
24
1 mg/ml
2-8°C
24
2 mg/ml
2-8°C
24
+
+
+
Amikacin sulfate
+
Caspofungin acetate
+
Ciprofloxacin lactate
+
Daptomycin
+
Dobutamine hydrochloride
+
Famotidine
+
Filgrastim
+
Gentamicin sulfate
+
Hydromorphone hydrochloride
+
Levofloxacine
+
Lorazepam
+
Meropenem
+
Micafungin
+
Morphine sulfate
+
Norepinephrine bitartrate
+
Potassium chloride
+
Vancomycin hydrochloride
Potassium chloride
+
Posaconazole
Vancomycin hydrochloride
+
Posaconazole
Mentions Légales
